The global bioinformatics platforms market is expected to grow from USD 1.5 billion in 2017 to USD 2.6 billion by 2030, at a CAGR of 8.2% during the forecast period. The major factors driving the growth of this market are increasing demand for personalized medicine and growing need for drug development and discovery.
The global bioinformatics platforms market is segmented on the basis of type, application, and region. On the basis of type, it is classified into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural & functional analysis platforms; on the basis of application it is classified into drug development, molecular genomics, personalized medicine (gene therapy), protein function analysis; on the basis of region it is classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa (APMEA).
- Bioinformatics Platforms market growth is driven by the need for better understanding of biological processes and systems.
- Bioinformatics Platforms market growth is driven by the need to develop new drugs and treatments for diseases such as cancer, diabetes, Alzheimer's disease, Parkinson's disease, and HIV/AIDS.
- Bioinformatics Platforms market growth is driven by the need to develop new vaccines against emerging infectious diseases such as Ebola virus disease (EVD), Middle East Respiratory Syndrome (MERS), Zika virus infection, and avian influenza.
- Bioinformatics Platforms market growth is driven by the need to understand how genes are regulated in order to identify genetic causes of human diseases.
- Bioinformatics Platforms market growth is driven by increasing demand from pharmaceutical companies.
Industry Growth Insights published a new data on “Bioinformatics Platforms Market”. The research report is titled “Bioinformatics Platforms Market research by Types (Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural & Functional Analysis Platforms, Others, ), By Applications (Drug Development, Molecular Genomics, Personalized Medicine, Gene Therapy, Protein Function Analysis, Others, ), By Players/Companies Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, GenoLogics Life Sciences, Illumina, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioinformatics Platforms Market Research Report
By Type
Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural & Functional Analysis Platforms, Others,
By Application
Drug Development, Molecular Genomics, Personalized Medicine, Gene Therapy, Protein Function Analysis, Others,
By Companies
Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, GenoLogics Life Sciences, Illumina,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Bioinformatics Platforms Market Report Segments:
The global Bioinformatics Platforms market is segmented on the basis of:
Types
Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural & Functional Analysis Platforms, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Development, Molecular Genomics, Personalized Medicine, Gene Therapy, Protein Function Analysis, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Affymetrix
- Dassault Systemes
- Agilent Technologies
- QIAGEN
- ID Business Solutions
- GenoLogics Life Sciences
- Illumina
Highlights of The Bioinformatics Platforms Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sequence Analysis Platforms
- Sequence Alignment Platforms
- Sequence Manipulation Platforms
- Structural & Functional Analysis Platforms
- Others
- By Application:
- Drug Development
- Molecular Genomics
- Personalized Medicine
- Gene Therapy
- Protein Function Analysis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioinformatics Platforms Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioinformatics platforms are computer systems that allow researchers to share and access data, tools, and services related to the analysis of biological information. Bioinformatics platforms can be used for a variety of purposes, including the discovery and analysis of new genes or proteins; the interpretation of genetic data; the development or improvement of bioinformatics algorithms; and the management and sharing of large-scale genomic databases.
Some of the major companies in the bioinformatics platforms market are Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, GenoLogics Life Sciences, Illumina.
The bioinformatics platforms market is expected to register a CAGR of 8.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bioinformatics Platforms Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bioinformatics Platforms Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bioinformatics Platforms Market - Supply Chain
4.5. Global Bioinformatics Platforms Market Forecast
4.5.1. Bioinformatics Platforms Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bioinformatics Platforms Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bioinformatics Platforms Market Absolute $ Opportunity
5. Global Bioinformatics Platforms Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bioinformatics Platforms Market Size and Volume Forecast by Type
5.3.1. Sequence Analysis Platforms
5.3.2. Sequence Alignment Platforms
5.3.3. Sequence Manipulation Platforms
5.3.4. Structural & Functional Analysis Platforms
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bioinformatics Platforms Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bioinformatics Platforms Market Size and Volume Forecast by Application
6.3.1. Drug Development
6.3.2. Molecular Genomics
6.3.3. Personalized Medicine
6.3.4. Gene Therapy
6.3.5. Protein Function Analysis
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bioinformatics Platforms Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bioinformatics Platforms Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bioinformatics Platforms Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bioinformatics Platforms Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bioinformatics Platforms Demand Share Forecast, 2019-2026
9. North America Bioinformatics Platforms Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bioinformatics Platforms Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bioinformatics Platforms Market Size and Volume Forecast by Application
9.4.1. Drug Development
9.4.2. Molecular Genomics
9.4.3. Personalized Medicine
9.4.4. Gene Therapy
9.4.5. Protein Function Analysis
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bioinformatics Platforms Market Size and Volume Forecast by Type
9.7.1. Sequence Analysis Platforms
9.7.2. Sequence Alignment Platforms
9.7.3. Sequence Manipulation Platforms
9.7.4. Structural & Functional Analysis Platforms
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bioinformatics Platforms Demand Share Forecast, 2019-2026
10. Latin America Bioinformatics Platforms Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bioinformatics Platforms Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bioinformatics Platforms Market Size and Volume Forecast by Application
10.4.1. Drug Development
10.4.2. Molecular Genomics
10.4.3. Personalized Medicine
10.4.4. Gene Therapy
10.4.5. Protein Function Analysis
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bioinformatics Platforms Market Size and Volume Forecast by Type
10.7.1. Sequence Analysis Platforms
10.7.2. Sequence Alignment Platforms
10.7.3. Sequence Manipulation Platforms
10.7.4. Structural & Functional Analysis Platforms
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bioinformatics Platforms Demand Share Forecast, 2019-2026
11. Europe Bioinformatics Platforms Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bioinformatics Platforms Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bioinformatics Platforms Market Size and Volume Forecast by Application
11.4.1. Drug Development
11.4.2. Molecular Genomics
11.4.3. Personalized Medicine
11.4.4. Gene Therapy
11.4.5. Protein Function Analysis
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bioinformatics Platforms Market Size and Volume Forecast by Type
11.7.1. Sequence Analysis Platforms
11.7.2. Sequence Alignment Platforms
11.7.3. Sequence Manipulation Platforms
11.7.4. Structural & Functional Analysis Platforms
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bioinformatics Platforms Demand Share, 2019-2026
12. Asia Pacific Bioinformatics Platforms Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bioinformatics Platforms Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bioinformatics Platforms Market Size and Volume Forecast by Application
12.4.1. Drug Development
12.4.2. Molecular Genomics
12.4.3. Personalized Medicine
12.4.4. Gene Therapy
12.4.5. Protein Function Analysis
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bioinformatics Platforms Market Size and Volume Forecast by Type
12.7.1. Sequence Analysis Platforms
12.7.2. Sequence Alignment Platforms
12.7.3. Sequence Manipulation Platforms
12.7.4. Structural & Functional Analysis Platforms
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bioinformatics Platforms Demand Share, 2019-2026
13. Middle East & Africa Bioinformatics Platforms Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bioinformatics Platforms Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bioinformatics Platforms Market Size and Volume Forecast by Application
13.4.1. Drug Development
13.4.2. Molecular Genomics
13.4.3. Personalized Medicine
13.4.4. Gene Therapy
13.4.5. Protein Function Analysis
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bioinformatics Platforms Market Size and Volume Forecast by Type
13.7.1. Sequence Analysis Platforms
13.7.2. Sequence Alignment Platforms
13.7.3. Sequence Manipulation Platforms
13.7.4. Structural & Functional Analysis Platforms
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bioinformatics Platforms Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bioinformatics Platforms Market: Market Share Analysis
14.2. Bioinformatics Platforms Distributors and Customers
14.3. Bioinformatics Platforms Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Affymetrix
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dassault Systemes
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. QIAGEN
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ID Business Solutions
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GenoLogics Life Sciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Illumina
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
